Some clinics sell hope more than evidence—asking the right questions is your best safety move.
Before you commit to stem cell treatment, get clear answers about who will treat you, what cells are used, and what realistic results look like.
This guide gives a concise safety and success checklist you can use at your appointment.
You’ll learn what to ask about provider credentials, cell source and lab handling, documented outcomes, written consent, and a full itemized cost so you can compare clinics and avoid costly surprises.
Essential Questions to Ask Before Selecting a Stem Cell Clinic

Before you commit to stem cell therapy, you need straight answers about safety, who’s actually treating you, and what realistic outcomes look like. A lot of clinics operate outside FDA approval. Your best protection? Asking the right questions before you book anything.
Start with the basics. Who’s going to evaluate you? Who performs the procedure? Who handles follow-up? The treating physician should manage all three. Sales staff shouldn’t be making medical calls. Ask about board certification that matches your diagnosis. Orthopedic surgery for joints. Physical medicine and rehab for musculoskeletal issues. Board certification needs to be ABMS-recognized and current. Verify it yourself through your state medical board. Takes about five minutes. Don’t just trust what the clinic tells you.
Here are eight questions to ask at every clinic:
- What’s your board certification, and does it actually match the specialty treating my condition?
- How many of these specific procedures have you done, and over what time period?
- What peer-reviewed, published research backs this treatment for my exact diagnosis?
- Are the cells autologous or allogeneic, and what safety protocols do you follow?
- What are the documented complication rates for this procedure, and how do you track adverse events?
- What sterility and emergency procedures are in place?
- Do you have current hospital privileges, and is your facility accredited?
- Can you provide written informed consent, a full cost breakdown, and a clear follow-up plan before I make any payment?
Use a checklist to compare answers across providers. Rank specialty fit and safety above cost. If you’re getting vague answers or missing critical info, delay and get a second opinion.
Understanding the Types of Stem Cell Treatments Available

Stem cell therapies vary a lot by cell source, how they’re processed, and whether they’re actually regulated. Understanding the major categories helps you ask smarter questions about what a clinic offers and why.
Autologous therapies use cells from your own body. Bone marrow or fat tissue, harvested and reinjected the same day. Allogeneic therapies use cells from someone else, often umbilical cord tissue, screened and processed in a lab before use. Autologous cells eliminate immune rejection risk, but they might contain aging or damaged cells. Allogeneic products can offer higher cell counts and more consistent quality if screened properly. But they introduce infection and contamination risks if donor screening or lab controls aren’t tight.
Minimally manipulated cells fall under certain FDA exemptions. Expanded or significantly altered cells need full regulatory approval or an Investigational New Drug (IND) application. Most marketed therapies sit in a gray zone, so you need to ask whether the product is FDA-approved, under an active IND, or operating outside formal oversight.
Here’s a quick breakdown:
- Autologous bone marrow or adipose-derived cells for same-day, same-surgical-procedure use
- Allogeneic umbilical cord–derived mesenchymal stem cells processed in a laboratory
- Platelet-rich plasma (PRP), often combined with stem cell procedures but technically a separate product
- Expanded or cultured cells requiring IND approval or formal clinical trial enrollment
Ask the clinic to clarify which type they use, how the cells are processed, and what regulatory pathway applies to your treatment.
Evaluating Clinic Safety and Compliance Standards

Clinic safety comes down to FDA regulations, facility accreditation, and transparent quality control. The FDA regulates human cells, tissues, and cellular products under 21 CFR 1271. That covers donor screening, infectious disease testing, sterility, and informed consent. Even if a clinic says it’s “FDA registered,” that doesn’t mean the therapy is FDA-approved or legal for routine use. Registration is just a basic administrative step. It’s not proof of safety or effectiveness.
Treatment should happen in a legitimate medical facility. A hospital or accredited surgery center with documented sterility protocols, clean-room processing, and single-use equipment. Infection control procedures, on-site emergency equipment, and hospital transfer protocols need to be in place. With proper technique and controls, infection risk should be less than 1%. The risk jumps in clinics without appropriate safeguards.
Ask whether the facility holds current accreditation from recognized bodies and whether the treating physician has active hospital privileges. Providers without privileges might lack peer oversight and emergency backup.
Verify these safety factors before booking:
| Safety Factor | What to Verify |
|---|---|
| Regulatory compliance | Confirm 21 CFR 1271 adherence; ask if treatment is FDA-approved, under an IND, or investigational outside oversight. |
| Facility standards | Require accreditation (e.g., AAAASF, AAAHC) and ask for documentation of clean-room or sterile processing areas. |
| Sterility practices | Ask about donor screening, infectious disease testing, single-use equipment, and how contamination is prevented. |
| Emergency readiness | Confirm presence of emergency equipment, trained personnel, and a transfer protocol to a nearby hospital. |
| Adverse event reporting | Ask how complications are tracked, reported, and whether the clinic participates in a registry or outcomes database. |
Request written documentation of these safety measures before agreeing to treatment. If the clinic can’t or won’t provide it, consider that a major red flag.
Assessing Evidence and Expected Outcomes

Most stem cell therapies marketed for orthopedic or degenerative conditions don’t have strong clinical evidence. Anecdotal success stories and patient testimonials aren’t substitutes for peer-reviewed, controlled trial data. Ask the clinic to show you condition-specific published research that demonstrates measurable improvement in patients like you. If the only evidence is internal case series or vague claims of “thousands of successful procedures,” verify those numbers yourself and look for published safety reports or registry data.
Outcomes vary. Some patients report improvement before leaving the clinic. Others might take up to six months to notice changes. Some see no effect. The clinic should define success with measurable endpoints like pain reduction, function scores, mobility tests, or activity restoration. Request objective baseline and follow-up measures. If the clinic refuses to discuss potential non-response or frames every outcome as positive, that’s a warning sign.
Use this three-step process to validate a clinic’s evidence:
- Ask for the full citation of peer-reviewed studies supporting the treatment for your diagnosis, then search PubMed or Google Scholar to confirm the studies exist and aren’t being misrepresented.
- Request the clinic’s own complication rates and documented adverse events with incidence figures and duration. Compare them to published norms.
- Confirm whether the treatment is part of a registered clinical trial with trackable enrollment, or whether it’s purely fee-for-service care outside formal research protocols.
Delay treatment if you can’t confirm credible evidence or if the clinic evades these questions.
Cost, Financing, and Insurance Considerations

Stem cell therapy is almost always cash-pay. Treatment prices commonly range from $3,000 to $15,000 per session, depending on cell source, procedure complexity, and whether additional services like physical therapy or imaging are included. Some international clinics quote higher all-inclusive packages starting at $15,825 for pediatric protocols or $26,900 for adult multi-session protocols that include hotel, ground transportation, and VIP customs assistance. Insurance companies typically don’t cover non-approved therapies, so you pay out of pocket with no guarantee of reimbursement or medical tax deduction.
Ask for a written total cost that itemizes every component. Consultation fees, lab work, imaging, the procedure itself, follow-up visits, physical therapy, supplements, emergency care, and any potential repeat sessions. Clarify cancellation and refund policies before making any deposit. Watch out for high-pressure financing offers or clinics that push immediate payment to “lock in a discount.” A legitimate provider gives you time to review contracts, compare options, and seek a second opinion. Second opinions typically cost $200 to $500 and are strongly recommended, especially if the treatment plan differs significantly from standard care or if you’re considering traveling internationally for therapy.
Identifying Red Flags and High-Risk Clinics

Certain warning signs should make you pause or walk away immediately. Guarantees of 100% success, “miracle cure” claims, or promises to reverse incurable diseases are red flags. Stem cell therapy might improve symptoms and quality of life, but it’s not a guaranteed cure for genetic or degenerative conditions. One-size-fits-all treatment protocols for unrelated conditions, like the same IV infusion marketed for knee arthritis, multiple sclerosis, and traumatic brain injury, signal the clinic isn’t tailoring therapy to your diagnosis or underlying biology.
Inability or refusal to provide published evidence, outcome data, or complication rates is a deal-breaker. If the clinic can’t name the cell source, describe donor screening protocols, or explain how cell lots are selected and released, the quality control might be nonexistent. Absence of written informed consent or pressure to sign forms without time to review them is a major warning. Legitimate providers offer detailed risk disclosure, alternative treatment discussion, and clear aftercare instructions before you commit.
Watch for these critical red flags:
- Clinic personnel are sales staff, not licensed medical professionals making treatment decisions.
- Provider lacks board certification relevant to your condition or refuses to share credentials for independent verification.
- No hospital privileges or facility accreditation, or evasive answers about emergency protocols.
- Vague or inconsistent patient and procedure counts, like claiming “13,000+ patients over 15 years” in one place and “50,000+ procedures since 2008” in another.
- Treatment takes place in a spa, wellness center, or hotel suite instead of a licensed medical facility.
- Clinic operates entirely outside the U.S. or advertises explicitly that it avoids FDA oversight.
If you encounter any of these, delay treatment and get at least one independent second opinion from a board-certified specialist who doesn’t perform stem cell procedures.
Questions to Ask About Risks, Side Effects, and Aftercare

Every medical procedure carries risk. Stem cell therapy is no exception. Potential complications include infection, immune reactions, unintended tissue formation, nerve damage, and procedure-specific risks like headache or fever after lumbar puncture. Short-term side effects reported in less than 10% of patients include minor fever, headache, nausea, or vomiting, typically resolving within 24 hours and never exceeding three days. Local injection pain is possible. With proper sterile technique, serious adverse events should be rare, but the clinic must track and disclose them.
Ask for a written informed consent document that lists the main risks, benefits, and alternatives. Confirm who manages your follow-up care, when short-term and long-term monitoring occurs, and how complications are reported and addressed. Expect follow-up contact within one to two weeks and structured long-term monitoring over three to twelve months with documented outcome assessments. Ask about lifestyle recommendations, like avoiding alcohol and tobacco, which can harm new stem cells and reduce treatment effectiveness.
Ask these five aftercare questions before proceeding:
- What specific short-term and long-term risks apply to my diagnosis and administration route?
- What follow-up schedule will you provide, and will it include objective outcome measures or just subjective check-ins?
- If I experience complications after returning home, who do I contact and what local care options are available?
- Are there written aftercare instructions covering activity restrictions, medication adjustments, physical therapy, and supplement recommendations?
- How do you track and report adverse events, and will I have access to my outcome data for my own records?
Refuse to proceed if the clinic can’t answer these questions clearly or dismisses risk discussion as unnecessary.
Final Words
Ask hard, practical questions first: provider credentials, treatment type, safety steps, evidence, costs, red flags, and aftercare. That keeps you in control.
You saw clear sections on treatment types, clinic compliance, how to vet evidence, cost transparency, warning signs, and post‑care needs. Use the checklists and sample questions we gave.
Treat what questions to ask before stem cell treatment as your safety checklist. Compare clinics, get itemized quotes, confirm follow‑up, and choose a provider who puts safety first. You can make a smarter choice and protect your movement and budget.
FAQ
Q: What not to do before stem cell therapy?
A: Before stem cell therapy, avoid NSAIDs and blood thinners, stop smoking and heavy alcohol, skip steroid injections and intense workouts, and follow your clinic’s prep list and medication instructions.
Q: What are some questions to ask about stem cells?
A: Questions to ask about stem cells include the cell source, evidence for your condition, provider credentials, treatment protocol, safety testing, expected outcomes, costs, follow-up plan, and refund or complication policies.
Q: Who is not a good candidate for stem cell therapy?
A: People not good candidates for stem cell therapy include those with active infections, uncontrolled diabetes, bleeding disorders, recent cancer, pregnancy, or severe immune dysfunction; eligibility depends on diagnosis and provider assessment.
Q: Can people with Hashimoto’s donate stem cells?
A: People with Hashimoto’s donating stem cells face case-by-case rules: controlled thyroid disease may allow donation, but active autoimmune activity or certain meds can disqualify; always check with the clinic and your endocrinologist.


